|Articles|May 7, 2023
- Pharmaceutical Executive: May 2023
- Volume 43
- Issue 5
Pharmaceutical Executive, May 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive May 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 3 years ago
From Science to Strategy | 2023 Emerging Pharma Leaderabout 3 years ago
Committed to the Cause | 2023 Emerging Pharma Leaderabout 3 years ago
A Knack for Problem-Solving | 2023 Emerging Pharma Leaderabout 3 years ago
Mission-Fueled Mindset | 2023 Emerging Pharma Leaderabout 3 years ago
Rejuvenating Lives | 2023 Emerging Pharma Leaderabout 3 years ago
Optimized for Growth? Revenue Management in Pharmaabout 3 years ago
Preparing for the End of the COVID Health Emergencyabout 3 years ago
AI is a Tool, Not a Replacement for Employeesabout 3 years ago
Ratings and Rankings: ESG Fundamentals for Pharma LeadersAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
The Power of Better Questions: How Great Leaders Balance Risk, Growth and Curiosity
5